There is an increasing spectrum of available therapies for patients with cancer, which has improved the outcomes of varied cancer types. At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Robin Foà , MD, from Sapienza University, Rome, Italy, explains some of the challenges with improving sustainability, access and quality of new treatments around the world.